At the beginning of the 21st century, a new paradigm was introduced for the evaluation of surrogate endpoints based on meta-analysis. In this paradigm, the putative surrogate is assessed at two different levels, the so-called, trial and individual level. Trial level surrogacy is defined as the association between the expected causal treatment effects across different trials populations, whereas the individual level is defined as the association between the surrogate and true endpoints, after adjusting by trial and treatment. It has been argued that the individual level surrogacy does not have a causal interpretation and, consequently, it is a poor metric of surrogacy. In the present work, an alternative definition of individual level surrog...
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted ...
In this paper, we show that Prentice's criteria for surrogates can be strengthened to remedy so...
A surrogate end point is often used to evaluate the effects of treatments or exposures on the true e...
Nowadays, two main frameworks for the evaluation of surrogate endpoints, based on causal-inference a...
The validation of surrogate endpoints has been studied by Prentice, who presented a definition as we...
The increasing cost of drug development has raised the demand for surrogate endpoints when evaluatin...
Various meta-analytical approaches have been applied to evaluate putative surrogate endpoints (S) of...
The relationship between association and surrogacy has been the focus of much debate in the surrogat...
A surrogate endpoint is intended to replace a clinical endpoint for the evaluation of new treatments...
This thesis considers a range of methodological challenges related to the trial-level validation of ...
In this work a new metric of surrogacy, the so-called individual causal association (ICA), is introd...
Several methods have been developed for the evaluation of surrogate endpoints within the causal-infe...
The individual causal association (ICA) has recently been introduced as a metric of surrogacy in a c...
Two paradigms for the evaluation of surrogate markers in randomized clinical trials have been propos...
Abstract–In spite of medical and methodological advances, the identification of good surrogate endpo...
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted ...
In this paper, we show that Prentice's criteria for surrogates can be strengthened to remedy so...
A surrogate end point is often used to evaluate the effects of treatments or exposures on the true e...
Nowadays, two main frameworks for the evaluation of surrogate endpoints, based on causal-inference a...
The validation of surrogate endpoints has been studied by Prentice, who presented a definition as we...
The increasing cost of drug development has raised the demand for surrogate endpoints when evaluatin...
Various meta-analytical approaches have been applied to evaluate putative surrogate endpoints (S) of...
The relationship between association and surrogacy has been the focus of much debate in the surrogat...
A surrogate endpoint is intended to replace a clinical endpoint for the evaluation of new treatments...
This thesis considers a range of methodological challenges related to the trial-level validation of ...
In this work a new metric of surrogacy, the so-called individual causal association (ICA), is introd...
Several methods have been developed for the evaluation of surrogate endpoints within the causal-infe...
The individual causal association (ICA) has recently been introduced as a metric of surrogacy in a c...
Two paradigms for the evaluation of surrogate markers in randomized clinical trials have been propos...
Abstract–In spite of medical and methodological advances, the identification of good surrogate endpo...
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted ...
In this paper, we show that Prentice's criteria for surrogates can be strengthened to remedy so...
A surrogate end point is often used to evaluate the effects of treatments or exposures on the true e...